RAPPRapport Therapeutics, Inc.

Nasdaq www.rapportrx.com


$ 23.51 $ -1.78 (-7.04 %)    

Wednesday, 03-Jul-2024 12:09:50 EDT
QQQ $ 490.33 $ 3.86 (0.79 %)
DIA $ 392.48 $ -1.29 (-0.33 %)
SPY $ 550.56 $ 1.96 (0.36 %)
TLT $ 91.64 $ 0.47 (0.52 %)
GLD $ 218.35 $ 1.04 (0.48 %)
$ 25.01
$ 25.29
$ 0.00 x 0
$ 0.00 x 0
$ 23.17 - $ 25.29
$ 18.00 - $ 27.11
227,599
na
0
$ 9.93
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

TD Cowen analyst Joseph Thome initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating.

Core News & Articles

Jefferies analyst Andrew Tsai initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating and announces Price...

Core News & Articles

Stifel analyst Paul Matteis initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating and announces Price T...